Page last updated: 2024-11-02

pirenzepine and Sicca Syndrome

pirenzepine has been researched along with Sicca Syndrome in 3 studies

Pirenzepine: An antimuscarinic agent that inhibits gastric secretion at lower doses than are required to affect gastrointestinal motility, salivary, central nervous system, cardiovascular, ocular, and urinary function. It promotes the healing of duodenal ulcers and due to its cytoprotective action is beneficial in the prevention of duodenal ulcer recurrence. It also potentiates the effect of other antiulcer agents such as CIMETIDINE and RANITIDINE. It is generally well tolerated by patients.

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (33.33)18.2507
2000's1 (33.33)29.6817
2010's1 (33.33)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Passafaro, D1
Reina, S2
Sterin-Borda, L3
Borda, E3
Orman, B1
De Couto Pita, A1
Bacman, S1
Camusso, JJ1
Arana, R1
Hubscher, O1

Other Studies

3 other studies available for pirenzepine and Sicca Syndrome

ArticleYear
Cholinergic autoantibodies from primary Sjögren's syndrome modulate submandibular gland Na+/K+-ATPase activity via prostaglandin E2 and cyclic AMP.
    European journal of oral sciences, 2010, Volume: 118, Issue:2

    Topics: Adult; Animals; Autoantibodies; Cells, Cultured; Cyclic AMP; Dinoprostone; Female; Humans; Immunoglo

2010
Anti-brain cholinergic auto antibodies from primary Sjögren syndrome sera modify simultaneously cerebral nitric oxide and prostaglandin biosynthesis.
    International immunopharmacology, 2007, Dec-05, Volume: 7, Issue:12

    Topics: Adult; Animals; Autoantibodies; Cerebral Cortex; Cyclooxygenase 1; Cyclooxygenase 2; Dinoprostone; D

2007
Circulating antibodies against rat parotid gland M3 muscarinic receptors in primary Sjögren's syndrome.
    Clinical and experimental immunology, 1996, Volume: 104, Issue:3

    Topics: Adolescent; Adrenergic beta-Agonists; Adult; Animals; Antibodies, Blocking; Atropine; Carbachol; Car

1996